MacroGenics, Inc. (MGNX)
3.10
+0.10
(+3.33%)
USD |
NASDAQ |
Mar 16, 16:00
3.08
-0.02
(-0.65%)
After-Hours: 20:00
MacroGenics Shareholders Equity (Quarterly) : 55.59M for Dec. 31, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Amgen, Inc. | 8.658B |
| Amicus Therapeutics, Inc. | 274.24M |
| Merck & Co., Inc. | 52.61B |
| CorMedix, Inc. | 405.31M |
| Xencor, Inc. | 635.59M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 264.57M |
| Total Liabilities (Quarterly) | 208.98M |
| Debt to Equity Ratio | 1.920 |
| Current Ratio | 5.101 |
| Net Debt Paydown Yield | -14.26% |